Degousee Norbert, Angoulvant Denis, Fazel Shafie, Stefanski Eva, Saha Sipra, Iliescu Karina, Lindsay Thomas F, Fish Jason E, Marsden Philip A, Li Ren-Ke, Audoly Laurent P, Jakobsson Per-Johan, Rubin Barry B
Divisions of Vascular Surgery and Cardiac Surgery, Toronto General Hospital Research Institute of the University Health Network, University of Toronto, Toronto, Ontario M5G-2C4, Canada.
J Biol Chem. 2006 Jun 16;281(24):16443-52. doi: 10.1074/jbc.M602815200. Epub 2006 Apr 19.
Microsomal prostaglandin (PG) E(2) synthase-1 (mPGES-1) catalyzes the terminal step in the biosynthesis of PGE(2), a key proinflammatory mediator. The purpose of this study was to elucidate the regulation of mPGES-1 mRNA expression in cardiomyocytes, define the role of JNK enzymes in this process, and characterize the role of mPGES-1 in cardiomyocyte PGE(2) biosynthesis. In neonatal cardiomyocytes, interleukin-1beta and lipopolysaccharide (LPS) both stimulated mPGES-1 mRNA expression and increased mPGES-1 mRNA stability and protein synthesis but failed to increase mPGES-1 mRNA transcription. Treatment with the JNK1/2 inhibitor, SP600125, abrogated the increases in mPGES-1 mRNA stability, mPGES-1 protein synthesis, and PGE(2) release induced by interleukin-1beta or LPS. mPGES-1 protein synthesis was observed in LPS-stimulated neonatal cardiomyocytes from jnk1(-/-) or jnk2(-/-) mice. In contrast, infection of jnk1(-/-) cardiomyocytes with an adenovirus encoding phosphorylation-resistant JNK2 (ad-JNK2-DN), or of jnk2(-/-) cardiomyocytes with ad-JNK1-DN, significantly decreased LPS-stimulated mPGES-1 protein synthesis. Similarly, co-infection with ad-JNK1-DN and ad-JNK2-DN attenuated LPS-stimulated mPGES-1 protein synthesis in cardiomyocytes from wild type mice. Targeted deletion of the gene encoding mPGES-1 led to a 3.2-fold decrease in LPS-stimulated PGE(2) release by cardiomyocytes in comparison with wild type cells but had no effect on COX-1, COX-2, mPGES-2, or cytosolic PGES mRNA levels. These studies provide direct evidence that mPGES-1 mRNA levels in cardiomyocytes are augmented by stabilization of mPGES-1 mRNA, that JNK1 or JNK2 can participate in the regulation of mPGES-1 protein synthesis in these cells, and that mPGES-1 catalyzes the majority of LPS-induced PGE(2) biosynthesis by cardiomyocytes.
微粒体前列腺素(PG)E2合酶-1(mPGES-1)催化关键促炎介质PGE2生物合成的最后一步。本研究的目的是阐明心肌细胞中mPGES-1 mRNA表达的调控机制,确定JNK酶在此过程中的作用,并描述mPGES-1在心肌细胞PGE2生物合成中的作用。在新生心肌细胞中,白细胞介素-1β和脂多糖(LPS)均刺激mPGES-1 mRNA表达,增加mPGES-1 mRNA稳定性和蛋白质合成,但未能增加mPGES-1 mRNA转录。用JNK1/2抑制剂SP600125处理可消除白细胞介素-1β或LPS诱导的mPGES-1 mRNA稳定性增加、mPGES-1蛋白质合成增加以及PGE2释放增加。在来自jnk1(-/-)或jnk2(-/-)小鼠的LPS刺激的新生心肌细胞中观察到mPGES-1蛋白质合成。相反,用编码磷酸化抗性JNK2的腺病毒(ad-JNK2-DN)感染jnk1(-/-)心肌细胞,或用ad-JNK1-DN感染jnk2(-/-)心肌细胞,可显著降低LPS刺激的mPGES-1蛋白质合成。同样,用ad-JNK1-DN和ad-JNK2-DN共同感染可减弱野生型小鼠心肌细胞中LPS刺激的mPGES-1蛋白质合成。与野生型细胞相比,靶向缺失编码mPGES-1的基因导致心肌细胞中LPS刺激的PGE2释放减少3.2倍,但对COX-1、COX-2、mPGES-2或胞质PGES mRNA水平无影响。这些研究提供了直接证据,表明心肌细胞中mPGES-1 mRNA水平通过mPGES-1 mRNA的稳定而增加,JNK1或JNK2可参与这些细胞中mPGES-1蛋白质合成的调控,并且mPGES-1催化心肌细胞中大部分LPS诱导的PGE2生物合成。